By Landon Gray
Originally published by our sister publication Infectious Disease Special Edition
Despite highly effective treatment for hepatitis C virus (HCV) in the United States insurance coverage, age and race have been barriers to treatment, according to a new report from the CDC.
“Everyone with hepatitis C should have access to highly effective treatments to cure the infection, regardless of age, race or insurance status,” said Debra E. Houry, MD, MPH, the CDC’s acting